SCHEMBL3663958

SCHEMBL3663958

c1ccc2c(c1)CNC2.c1ccc2c(c1)COC2

nearest known ligand 0.70

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.50
CD44 P16070 1/20 0.50
MAOB P27338 1/20 0.50
OXTR P30559 1/20 0.45
HTR2C P28335 2/20 0.39
RYR2 Q92736 1/20 0.38
ALOX15 P16050 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4506823 0.86 OXTR (0.52) PNMTCD44MAOBOXTRHTR2C
SCHEMBL59871 0.84
SCHEMBL29471383 0.84
SCHEMBL13590042 0.84 PNMT (0.65) PNMTCD44MAOBOXTRHTR2C
SCHEMBL29351494 0.84
SCHEMBL10612 0.84
Ammonia Solution, Strong SCHEMBL23320033 0.81 MAOA (0.40) MAOBOXTRHTR2C
Methane SCHEMBL11147358 0.81 PNMT (0.62) PNMTCD44MAOBOXTRHTR2C
SCHEMBL16439994 0.81
Ammonia Solution, Strong SCHEMBL16296133 0.81 PNMT (0.62) PNMTCD44MAOBOXTRHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010082912-A1 DERIVATIVES OF MULTI-RING AROMATIC COMPOUNDS AND USES AS ANTI-TUMOR AGENTS AVALON PHARMACEUTICALS (US) 2010-07-22 WO disclosed
EP-2141994-A1 MULTI-RING COMPOUNDS AND USES THEREOF Avalon Pharmaceuticals (US) 2010-01-13 EP disclosed
EP-2074126-A2 SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF Wyeth a Corporation of the State of Delaware (US) 2009-07-01 EP disclosed
EP-1991233-A4 HYDROXYPIPERIDINE DERIVATIVES AND USES THEREOF AVALON PHARMACEUTICALS (US) 2009-07-01 EP disclosed
EP-1991233-A2 HYDROXYPIPERIDINE DERIVATIVES AND USES THEREOF Avalon Pharmaceuticals (US) 2008-11-19 EP disclosed
WO-2008133975-A1 MULTI-RING COMPOUNDS AND USES THEREOF AVALON PHARMACEUTICALS (US) 2008-11-06 WO disclosed
WO-2008049105-A2 SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF WYETH (US) 2008-04-24 WO disclosed
WO-2007098086-A2 HYDROXYPIPERIDINE DERIVATIVES AND USES THEREOF AVALON PHARMACEUTICALS (US) 2007-08-30 WO disclosed
EP-1558580-A2 N-SULFONYL-4-METHYLENEAMINO-3-HYDROXY-2-PYRIDONES AS ANTIMICROBIAL AGENTS The Procter & Gamble Company (US) 2005-08-03 EP disclosed
EP-1558579-A1 N-ALKYL-4-METHYLENEAMINO-3-HYDROXY-2-PYRIDONES AS ANTIMICROBIALS THE PROCTER & GAMBLE COMPANY (US) 2005-08-03 EP disclosed
WO-2005016264-A2 DIAMINE DERIVATIVES OF QUINONE AND USES THEREOF AVALON PHARMACEUTICALS (US) 2005-02-24 WO disclosed
WO-2005011675-A1 DERIVATIVES OF 3-HYDROXY-PYRROLE-2,4-DICARBOXYLIC ACID AND USES THEREOF AVALON PHARMACEUTICALS (US) 2005-02-10 WO disclosed
WO-2004043927-A1 N-ALKYL-4-METHYLENEAMINO-3-HYDROXY-2-PYRIDONES AS ANTIMICROBIALS THE PROCTER & GAMBLE COMPANY (US) 2004-05-27 WO disclosed
WO-2004043928-A2 N-SULFONYL-4-METHYLENEAMINO-3-HYDROXY-2-PYRIDONES AS ANTIMICROBIAL AGENTS THE PROCTER & GAMBLE COMPANY (US) 2004-05-27 WO disclosed
EP-1265887-A2 CARBOCYCLIC SIDE CHAIN CONTAINING METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2002-12-18 EP disclosed
EP-1165501-A1 ALKENYL- AND ALKYNYL-CONTAINING METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2002-01-02 EP disclosed
WO-2001070682-A2 CARBOCYCLIC SIDE CHAIN CONTAINING METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2001-09-27 WO disclosed
WO-2000051975-A1 ALKENYL- AND ALKYNYL-CONTAINING METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-09-08 WO disclosed